PNAsTM miRNA inhibitors and negative control

      PNAs™ miRNA inhibitors released by Panagene, utilize proprietary properties of PNA (Peptide Nucleic Acid). PNAs™ miRNA inhibitors have higher specificity and stability. Transfection reagents are not needed for miRNA inhibition because of CPP (Cell Penetrating Peptide) conjugated to PNA.

Product features

a. Transfection reagents are not needed

b. Effective miRNA inhibitory activity

c. No cytotoxicity

d. No protease or nuclease degradation

e. Storage and handling at room temperature

f. Permanent preservation inside cells

Product information